Properdin: Difference between revisions

Latest revision as of 12:03, 15 February 2025

Properdin[edit]

Properdin is a protein that plays a crucial role in the immune system, specifically in the complement system. It is a positive regulator of the alternative pathway of complement activation, which is one of the three pathways that activate the complement system, an essential part of the innate immune response.

Structure[edit]

Properdin is a glycoprotein composed of multiple subunits. It is known to exist in different oligomeric forms, including dimers, trimers, and tetramers. These oligomeric forms are important for its function in stabilizing the alternative pathway convertase complexes.

Function[edit]

Properdin functions by binding to and stabilizing the C3 and C5 convertase enzyme complexes of the alternative pathway. This stabilization enhances the activity of these complexes, leading to increased cleavage of complement components C3 and C5, and ultimately, the formation of the membrane attack complex (MAC). The MAC is responsible for lysing pathogens and infected cells.

Role in the Alternative Pathway[edit]

The alternative pathway of complement activation is continuously active at a low level, providing a rapid response to pathogens. Properdin is unique among complement proteins because it acts as a positive regulator, enhancing the activity of the pathway. It binds to surfaces of pathogens and damaged cells, promoting the assembly and stability of the C3 convertase (C3bBb) and C5 convertase (C3bBbC3b) complexes.

Clinical Significance[edit]

Deficiencies in properdin can lead to increased susceptibility to infections, particularly those caused by Neisseria meningitidis, a bacterium responsible for meningitis. Conversely, excessive activation of the complement system, potentially involving properdin, can contribute to inflammatory diseases.

Research and Therapeutic Potential[edit]

Research into properdin and its role in the complement system is ongoing, with potential therapeutic applications in modulating the immune response. Targeting properdin may offer strategies for treating diseases involving complement dysregulation, such as autoimmune diseases and age-related macular degeneration.

Related Pages[edit]

@@ Line 1: / Line 1: @@
 == Properdin ==
-'''Properdin''' is a protein that plays a crucial role in the immune system's defense against infections. It is a part of the [[complement system]], which is a complex network of proteins that work together to eliminate pathogens and maintain immune homeostasis. Properdin acts as a positive regulator of the complement system, enhancing its activation and amplifying the immune response.
+[[File:Droga_alternatywna.png|thumb|right|Diagram of the alternative pathway of complement activation, highlighting the role of properdin.]]
-=== Structure ===
+'''Properdin''' is a protein that plays a crucial role in the [[immune system]], specifically in the [[complement system]]. It is a positive regulator of the [[alternative pathway]] of complement activation, which is one of the three pathways that activate the complement system, an essential part of the innate immune response.
-Properdin is a glycoprotein composed of seven identical subunits, each consisting of 53 amino acids. These subunits assemble into a ring-like structure known as a [[protease]]-resistant oligomer. The oligomerization of properdin is essential for its stability and function. It can exist in two forms: a soluble form found in the blood plasma and a cell-associated form found on the surface of certain immune cells.
+== Structure ==
+Properdin is a glycoprotein composed of multiple subunits. It is known to exist in different oligomeric forms, including dimers, trimers, and tetramers. These oligomeric forms are important for its function in stabilizing the alternative pathway convertase complexes.
-=== Function ===
+== Function ==
+Properdin functions by binding to and stabilizing the C3 and C5 convertase enzyme complexes of the alternative pathway. This stabilization enhances the activity of these complexes, leading to increased cleavage of complement components C3 and C5, and ultimately, the formation of the [[membrane attack complex]] (MAC). The MAC is responsible for lysing pathogens and infected cells.
-Properdin plays a crucial role in the alternative pathway of the complement system. When activated, properdin binds to the surface of pathogens, such as bacteria, and stabilizes the formation of the C3 convertase enzyme complex. This complex leads to the cleavage of C3 protein into C3a and C3b fragments. C3b then opsonizes the pathogen, marking it for phagocytosis by immune cells, while C3a recruits inflammatory cells to the site of infection.
+== Role in the Alternative Pathway ==
+The alternative pathway of complement activation is continuously active at a low level, providing a rapid response to pathogens. Properdin is unique among complement proteins because it acts as a positive regulator, enhancing the activity of the pathway. It binds to surfaces of pathogens and damaged cells, promoting the assembly and stability of the C3 convertase (C3bBb) and C5 convertase (C3bBbC3b) complexes.
-Furthermore, properdin also enhances the formation of the membrane attack complex (MAC), which is responsible for directly lysing pathogens. By stabilizing the C3 convertase and promoting MAC formation, properdin helps to efficiently eliminate pathogens and prevent their spread.
+== Clinical Significance ==
+Deficiencies in properdin can lead to increased susceptibility to infections, particularly those caused by [[Neisseria meningitidis]], a bacterium responsible for [[meningitis]]. Conversely, excessive activation of the complement system, potentially involving properdin, can contribute to inflammatory diseases.
-=== Regulation ===
+== Research and Therapeutic Potential ==
+Research into properdin and its role in the complement system is ongoing, with potential therapeutic applications in modulating the immune response. Targeting properdin may offer strategies for treating diseases involving complement dysregulation, such as [[autoimmune diseases]] and [[age-related macular degeneration]].
-The activity of properdin is tightly regulated to prevent excessive complement activation, which can lead to tissue damage and autoimmune diseases. Several regulatory proteins, such as factor H and factor I, interact with properdin to control its function. These proteins inhibit the formation and activity of the C3 convertase, ensuring a balanced immune response.
+== Related Pages ==
-=== Clinical Significance ===
-Deficiencies or dysregulation of properdin can have significant implications for immune function. Properdin deficiency is a rare genetic disorder that increases the susceptibility to recurrent infections, particularly with encapsulated bacteria. It can also lead to the development of autoimmune diseases, such as systemic lupus erythematosus.
-On the other hand, excessive properdin activity has been associated with certain inflammatory conditions, including age-related macular degeneration and atypical hemolytic uremic syndrome. Understanding the role of properdin in these diseases may provide insights into potential therapeutic targets.
-=== Conclusion ===
-Properdin is a vital component of the complement system, contributing to the immune response against infections. Its ability to enhance complement activation and promote pathogen elimination highlights its importance in maintaining immune homeostasis. Further research on properdin and its regulatory mechanisms may lead to the development of novel therapeutic strategies for immune-related disorders.
-== See Also ==
 * [[Complement system]]
-* [[Protease]]
+* [[Alternative pathway]]
-* [[Factor H]]
+* [[Membrane attack complex]]
-* [[Factor I]]
+* [[Neisseria meningitidis]]
-* [[Systemic lupus erythematosus]]
-* [[Age-related macular degeneration]]
-* [[Atypical hemolytic uremic syndrome]]
-== References ==
+[[Category:Immunology]]
-. Hourcade DE. The role of properdin in the assembly of the alternative pathway C3 convertases of complement. J Biol Chem. 2006;281(4):2128-2132. doi:10.1074/jbc.M509105200
+[[Category:Proteins]]
-. Kouser L, Abdul-Aziz M, Tsolaki AG, et al. A recombinant two-module form of human properdin is an inhibitor of the complement alternative pathway. Mol Immunol. 2017;89:158-166. doi:10.1016/j.molimm.2017.06.019
-{{dictionary-stub1}}